Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases

Journal of Clinical Oncology

Volumn 14, Issue 6, 1996, Pages 1943-1949

  Salloum, E ^a   Cooper, D L ^a   Howe, G ^a   Lacy, J ^a   Tallini, G ^a   Crouch, J ^a   Schultz, M ^a   Murren, J ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; METHOTREXATE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CANCER REGRESSION; CANCER RISK; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VIRUS CARCINOGENESIS;

EID: 0029886739     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.6.1943     Document Type: Article

References (56)

1. Symmons DP, Ahern M, Bacon PA, et al: Lymphoproliferative malignancy in rheumatoid arthritis: A study of 20 cases. Ann Rheum Dis 43:132-135, 1984
2. Isomaki HA, Mutru O, Joutsenlahti U: Excess risks of lymphoma, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis 31:691-699, 1978
3. Prior P, Symmons DP, Scott DL, et al: Causes of death in rheumatoid arthritis. Br J Rheumatol 23:92-99, 1984
4. Fries JF: Epidemiology of cancer in rheumatoid arthritis: Methodologic pitfalls. Am J Med 78:12-14, 1985 (suppl 1A)
5. Kinlen LJ: Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 78:44-49, 1985 (suppl 1A)
6. Prior P: Cancer and rheumatoid arthritis. Epidemiologic considerations. Am J Med 78:15-21, 1985 (suppl 1A)
7. Hakulinen T, Isomaki H, Knekt P: Rheumatoid arthritis and cancer studies based on linked nationwide registries in Finland. Am J Med 78:29-32, 1985 (suppl 1A)
8. Kassan SS, Thomas TL, Moutsopulos HM, et al: Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89:888-892, 1978
9. Symmons DPM: Neoplasia in rheumatoid arthritis. J Rheumatol 15:1319-1322, 1988
10. Kinlen LJ, Skeil AGR, Peto R, et al: Collaborative UK-Australian study of cancer in patients treated with immunosuppressive drugs. Br Med J 2:1461-1466, 1979
11. Urowitz M, Smythe H, Able T, et al: Long term effects of azathioprine in rheumatoid arthritis. Ann Rheum Dis 41:18-22, 1982 (suppl)
12. Farber SJ, Sheon RP, Kirsner AB, et al: Incidence of malignant diseases in patients receiving cytotoxic therapy for rheumatoid arthritis. Arthritis Rheum 22:608, 1979 (abstr)
13. Kirsner AB, Farber SJ, Sheon RP, et al: The incidence of malignant diseases in patients receiving cytotoxic therapy for rheumatoid arthritis. Ann Rheum Dis 41:32-33, 1982 (suppl)
14. Baltus J, Boersma J, Hartman A, et al: Occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide. Ann Rheum Dis 42:368-373, 1983
15. Laasko GL, Mutru O, Isomaki H, et al: Cancer mortality in patients with rheumatoid arthritis. J Rheumatol 13:522-526, 1986
16. Baker GL, Kohl LE, Zee BC, et al: Malignancy following treatment of rheumatoid arthritis with cyclophosphamide: Long-term case-control follow-up study. Am J Med 83:1-9, 1987
17. Silman AJ, Petrie J, Hazleman B, et al: Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: A 20 year follow-up study. Ann Rheum Dis 47:988-992, 1988
18. Gridley G, Klippel GH, Hoover RN, et al: Incidence of cancer among men with the Felty syndrome. Ann Intern Med 120:35-39, 1994
19. Bardwick PA, Bluestein HG, Zvaifler NJ, et al: Altered regulation of Epstein-Barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells. Arthritis Rheum 23:626-632, 1980
20. Depper JM, Bluestein HG, Zvaifler NJ: Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect. J Immunol 127:1899-1902, 1981
21. Depper JM, Zvaifler NJ: Epstein-Barr virus. Its relationship to the pathogenesis of rheumatoid arthritis. Arthritis Rheum 24:755-761, 1981
22. Vaughan JH: Immune system in rheumatoid arthritis: possible implications in neoplasms. Am J Med 78:6-11, 1985 (suppl 1A)
23. Tosato G, Steinberg AD, Yarchoan R, et al: Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest 73:1789-1795, 1984
24. Lewis P, Hazleman B, Hanka R, et al: Causes of death in patients with rheumatoid arthritis with particular reference to azathioprine. Ann Rheum Dis 39:457-461, 1980
25. Symmons DPM: Neoplasms of the immune system in rheumatoid arthritis. Am J Med 78:22-28, 1985 (suppl 1A)
26. Kamel OW, van De Rijn M, Weiss LM, et al: Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328:1317-1321, 1993
27. Shiroky JB, Frost A, Skelton JD, et al: Complications of immunosuppression associated with weekly low dose methotrexate. J Rheumatol 18:1172-1175, 1991
28. Lioté F, Pertuiset E, Cochand-Priolllet B, et al: Pseudolymphome B sous methotrexate (MTX) au cours de la polyarthrite rhumatoïde (PR). Rev Rhum Mal Osteoartic 59:369, 1992 (abstr)
29. Ellman MH, Hurwitz H, Thomas C, et al: Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18:1741-1743, 1991
30. Ivorra J, Massuti B, Roman J, et al: Artritis reumatoide y neoplasia multiple. Med Clin (Barc) 97:383-385, 1991
31. Kingsmore SF, Hall BD, Allen NB, et al: Association of methotrexate, rheumatoid arthritis and lymphoma: Report of 2 cases and literature review. J Rheumatol 19:1462-1465, 1992
32. Cobeta-Garcia JC, Ruiz-Jimeno MT, Fontova-Garrofe R. Non-Hodgkin's lymphoma, rheumatoid arthritis and methotrexate. J Rheumatol 20:200-202, 1993 (letter)
33. Taillan B, Gamier G, Castanet J, et al: Lymphoma developing in a patient with rheumatoid arthritis taking methotrexate. Clin Rheum 12:93-94, 1993
34. Kamel OW, van de Rijn, Lebrun DP, et al: Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: Frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 25:638-643, 1994
35. Zimmer-Galler I, Lie JT: Choroidal infiltrates as the initial manifestation of lymphoma in rheumatoid arthritis after treatment with low-dose methotrexate. Mayo Clin Proc 69:259-262, 1994
36. Morris CR, Morris AJ: Localized lymphoma in a patient with rheumatoid arthritis treated with parenteral methotrexate. J Rheum 20:2172-2173, 1993 (letter)
37. Kchir MM, Aloui S, Ben Taarit C, et al: Lymphome malin non hodgkinien et polyarthrite rhumatoïde. Sem Hop Paris 68:1457-1459, 1992
38. LeGoff P, Koreici A, Saraux A, et al: Lymphome au cours du traitement de la polyarthrite rhumatoïde par le methotrexate à faible dose: Un nouveau cas. Rev Rhum 61:357-363, 1994 (letter)
39. Ferraccioli GF, Casatta L, Bartoli E, et al: Epstein-Barr virus associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A. Arthritis Rheum 6:867-868, 1995 (letter)
40. Menke D, Griesser H, Moder K, et al: PCR detection of clonality and EBV in lymphomas arising after methotrexate therapy for connective tissue diseases. Mod Pathol 7:116A, 1994 (abstr)
41. Moder KG, Tefferi A, Cohen MD, et al: Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: A retrospective study. Am J Med 99:276-281, 1995
42. Chang KL, Chen YY, Shibata D, et al: Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol 1:246-255, 1992
43. Jaffe IA: New approaches to the management of rheumatoid arthritis. J Rheumatol 19:2-8, 1992
44. Slotkoff AT, Katz P: Approach to the patient with rheumatoid arthritis. Adv Intern Med 39:197-240, 1994
45. Emery P, Luqmani R, Gordon C: Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts. Br J Clin Pract 48:82-86, 1994
46. Weinblatt ME: Methotrexate for chronic diseases in adults. N Engl J Med 332:330-331, 1995
47. Alarcon GS, Lopez-Mendez A, Walter J, et al: Radiographic evidence of disease progression in methotrexate treated and non-methotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: A meta-analysis. J Rheumatol 19:1868-1873, 1992
48. Willkens RF: Resolve: Methotrexate is the drug of choice after NSAIDs in rheumatoid arthritis. Semin Arthritis Rheum 20:76-80, 1990
49. Sany J, Anaya JM, Lussiez V, et al: Treatment of rheumatoid arthritis with methotrexate: A prospective open longterm study of 191 cases. J Rheumatol 18:1323-1327, 1991
50. Alarcon GS, Tracy IC, Blackburn WD Jr: Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 32:671-676, 1989
51. Matteson EL, Hickey AR, Maguire L, et al: Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD registry. J Rheumatol 18:809-814, 1991
52. Bailin PL, Tindall JP, Roenigk HH Jr, et al: Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective prospective analysis. JAMA 232:359-362, 1975
53. McClain KL, Leach CT, Jenson HB, et al: Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med 332:12-18, 1995
54. Lee ES, Locker J, Nalesnik M, et al: The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 332:19-25, 1995
55. Sparano JA: Treatment of AIDS-related lymphomas. Curr Opin Oncol 7:442-449, 1995
56. Shiroky JB, Newkirk M: Reversible lymphomas. N Engl J Med 329:1657-1658, 1993 (letter)